Logo image of MGLD

MARYGOLD COMPANIES INC/THE (MGLD) Stock Fundamental Analysis

NYSEARCA:MGLD - NYSE Arca - US57403M1045 - Common Stock - Currency: USD

0.8844  +0.03 (+3.39%)

Fundamental Rating

3

Taking everything into account, MGLD scores 3 out of 10 in our fundamental rating. MGLD was compared to 232 industry peers in the Capital Markets industry. While MGLD has a great health rating, there are worries on its profitability. MGLD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MGLD had negative earnings in the past year.
MGLD had a negative operating cash flow in the past year.
MGLD had positive earnings in 4 of the past 5 years.
In multiple years MGLD reported negative operating cash flow during the last 5 years.
MGLD Yearly Net Income VS EBIT VS OCF VS FCFMGLD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

MGLD has a worse Return On Assets (-18.53%) than 87.93% of its industry peers.
MGLD has a worse Return On Equity (-25.55%) than 84.48% of its industry peers.
Industry RankSector Rank
ROA -18.53%
ROE -25.55%
ROIC N/A
ROA(3y)-1.94%
ROA(5y)4.01%
ROE(3y)-2.5%
ROE(5y)4.98%
ROIC(3y)N/A
ROIC(5y)N/A
MGLD Yearly ROA, ROE, ROICMGLD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

Looking at the Gross Margin, with a value of 73.63%, MGLD is in the better half of the industry, outperforming 79.31% of the companies in the same industry.
MGLD's Gross Margin has been stable in the last couple of years.
MGLD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.44%
GM growth 5Y-0.22%
MGLD Yearly Profit, Operating, Gross MarginsMGLD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

8

2. Health

2.1 Basic Checks

MGLD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MGLD has been increased compared to 5 years ago.
Compared to 1 year ago, MGLD has an improved debt to assets ratio.
MGLD Yearly Shares OutstandingMGLD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MGLD Yearly Total Debt VS Total AssetsMGLD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

MGLD has an Altman-Z score of 3.63. This indicates that MGLD is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.63, MGLD is in the better half of the industry, outperforming 79.31% of the companies in the same industry.
There is no outstanding debt for MGLD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.63
ROIC/WACCN/A
WACCN/A
MGLD Yearly LT Debt VS Equity VS FCFMGLD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

MGLD has a Current Ratio of 2.68. This indicates that MGLD is financially healthy and has no problem in meeting its short term obligations.
MGLD's Current ratio of 2.68 is fine compared to the rest of the industry. MGLD outperforms 77.59% of its industry peers.
MGLD has a Quick Ratio of 2.42. This indicates that MGLD is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of MGLD (2.42) is better than 75.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.68
Quick Ratio 2.42
MGLD Yearly Current Assets VS Current LiabilitesMGLD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for MGLD have decreased strongly by -227.04% in the last year.
Looking at the last year, MGLD shows a decrease in Revenue. The Revenue has decreased by -6.70% in the last year.
Measured over the past years, MGLD shows a small growth in Revenue. The Revenue has been growing by 4.03% on average per year.
EPS 1Y (TTM)-227.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.31%
Revenue 1Y (TTM)-6.7%
Revenue growth 3Y-6.29%
Revenue growth 5Y4.03%
Sales Q2Q%-10.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MGLD Yearly Revenue VS EstimatesMGLD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MGLD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MGLD Price Earnings VS Forward Price EarningsMGLD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MGLD Per share dataMGLD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MGLD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARYGOLD COMPANIES INC/THE

NYSEARCA:MGLD (6/6/2025, 8:09:17 PM)

0.8844

+0.03 (+3.39%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-08 2025-05-08
Earnings (Next)09-16 2025-09-16
Inst Owners0.46%
Inst Owner Change13.99%
Ins Owners7.77%
Ins Owner Change1.14%
Market Cap37.89M
AnalystsN/A
Price TargetN/A
Short Float %0.53%
Short Ratio5.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.21
P/FCF N/A
P/OCF N/A
P/B 1.56
P/tB 1.83
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.73
BVpS0.57
TBVpS0.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.53%
ROE -25.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.63%
FCFM N/A
ROA(3y)-1.94%
ROA(5y)4.01%
ROE(3y)-2.5%
ROE(5y)4.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.44%
GM growth 5Y-0.22%
F-Score2
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.03%
Cap/Sales 0.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.68
Quick Ratio 2.42
Altman-Z 3.63
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)11.16%
Cap/Depr(5y)35.12%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-227.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.31%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.7%
Revenue growth 3Y-6.29%
Revenue growth 5Y4.03%
Sales Q2Q%-10.82%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-119.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-288.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-274.51%
OCF growth 3YN/A
OCF growth 5YN/A